{
    "clinical_study": {
        "@rank": "16859", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      I.  Assess the safety and efficacy of 4-aminosalicylic acid in patients with mildly to\n      moderately severe ulcerative colitis."
        }, 
        "brief_title": "Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis", 
        "condition": "Ulcerative Colitis", 
        "condition_browse": {
            "mesh_term": [
                "Colitis", 
                "Colitis, Ulcerative", 
                "Ulcer"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: This is a randomized study.  Patients are stratified by extent of disease.\n\n      Patients are randomly assigned to oral 4-aminosalicylic acid (4-ASA) or placebo administered\n      daily for 6 weeks.  Optional 4-ASA is available to all patients for up to 1 year.\n\n      Concurrent therapy with low-dose sulfasalazine, prednisone, or equivalent is allowed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n          -  Mildly to moderately severe ulcerative colitis\n\n          -  Patient age: 18 to 80"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "30", 
        "firstreceived_date": "February 24, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004810", 
            "org_study_id": "199/12012", 
            "secondary_id": "UVT-12012"
        }, 
        "intervention": {
            "intervention_name": "-aminosalicylic acid", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Aminosalicylic Acid"
        }, 
        "keyword": [
            "gastrointestinal disorders", 
            "rare disease", 
            "ulcerative colitis"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "University of Vermont", 
            "last_name": "Warren L. Beeken", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "reference": {
            "PMID": "9052519", 
            "citation": "Beeken W, Howard D, Bigelow J, Trainer T, Roy M, Thayer W, Wild G. Controlled trial of 4-ASA in ulcerative colitis. Dig Dis Sci. 1997 Feb;42(2):354-8."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004810"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Vermont", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "June 1996", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2001"
    }, 
    "geocoordinates": {}
}